NCT05229159

Brief Summary

Phase angle determined by bioelectrical impedance analysis is a strong prognostic factor in several medical areas as clinical nutrition, nephrology, infectious disease, oncology. Inflammation, frailty status and fluid overload can lead to a phase angle decreased. Some studies support its use for risk stratification in intensive care unit and other in preoperative for cardiac surgery. The investigators would like to evaluate its relevance for risk stratification at intensive care unit admission in the context of postoperative cardiac surgery with cardiopulmonary bypass.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
220

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2021

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

November 22, 2021

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 8, 2022

Completed
Last Updated

February 8, 2022

Status Verified

January 1, 2022

Enrollment Period

4 months

First QC Date

November 22, 2021

Last Update Submit

January 27, 2022

Conditions

Keywords

phase anglecardiac surgerycardiopulmonary bypassrisk stratificationoutcomes

Outcome Measures

Primary Outcomes (1)

  • Area under the receiver operating characteristic curve to predict a composite criterion including in-hospital mortality or prolonged hospital length of stay.

    The phase angle's area under the receptor operative curve to predict a composite criteria evaluated at hospital discharge and combining: * In hospital mortality * Prolonged hospital length of stay, defined by an in hospital length of stay greater than the 75th percentile of length of stay in the study population"

    at 6 months after the cardiac surgery

Study Arms (1)

BiPOCS group

All patients of our centers admitted for postoperative care after cardiac surgery with cardiopulmonary bypass and receiving a bioelectrical impedance analysis at the admission.

Diagnostic Test: Bioelectrical impedance analysis

Interventions

Segmental multi-frequency bioelectrical impedance analysis are carried out at all patient admitted to our ICU for postoperative care after cardiac surgery with cardiopulmonary bypass. Our objective is to evaluate the relevance of phase angle to predict mortality or a prolonged hospital length of stay. Phase angle is evaluated at ICU admission and will be compared to well-known prognostic scores computed in preoperative (EuroSCORE II) and at day one after surgery (SOFA, CASUS and SAPS II).

BiPOCS group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults patients admitted in intensive care unit for postoperative care after cardiac surgery with cardiopulmonary bypass.

You may qualify if:

  • Age higher than 18
  • Cardiac surgery with cardiopulmonary bypass
  • Bioelectrical impedance analysis the day of the admission in intensive care unit

You may not qualify if:

  • Left ventricular assist device
  • Limitations des thérapeutiques actives en place pour le patient
  • Patient opposition to the use of his health data
  • Invalid bioelectrical impedance analysis
  • Advanced directives to withhold or withdraw life-sustaining treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital cardiologique Louis Pradel Groupe Hospitalier Est

Bron, Rhône, 69500, France

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 22, 2021

First Posted

February 8, 2022

Study Start

July 1, 2021

Primary Completion

October 31, 2021

Study Completion

November 30, 2021

Last Updated

February 8, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations